Medical Communications

Showing 15 posts of 6417 posts found.

shutterstock_141299494

Top UK doctors warn Boris Johnson that no-deal Brexit would cause key cancer therapy supply shortages

August 2, 2019 Manufacturing and Production, Medical Communications Cancer, NHS, UK, brexit, pharma

Top doctors from some of the UK’s foremost nuclear medicine associations have written a letter to recently-anointed Prime Minister Boris …
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

August 2, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pfizer dominated the headlines this week as the US firm closed its $9.8 billion merger with GSK and announced that …

AI accurately detects subtle signs of atrial fibrillation even in normal tests

August 2, 2019 Medical Communications AF, AI, ECG, atrial fibrillation, electrcardiogram, pharma

A new study from the Mayo Clinic shows that artificial intelligence (AI) can detect signs of atrial fibrillation (AF) in …
nucala-web

European approval for two new delivery formulations of GSK’s Nucala in severe eosinophilic asthma

August 2, 2019 Medical Communications, Sales and Marketing Europe, GSK, Nucala, asthma, pharma

Following closely on the heels of the news that its deal to merge Pfizer’s consumer health business with its own, …
image_credit_gage_skidmore

US presidential candidate Bernie Sanders pledges to allow Americans to import drugs from Canada

August 2, 2019 Medical Communications Bernie Sanders, Canada, Trump, US, democrats, prescription drugs

Democratic presidential candidate Bernie Sanders has said he will, on his first day in office, allow for the importation of …
survey-2316468_640

The patient is always right: Extracting the full value of PROMs

July 29, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, PROs, UK, feature, patient reported outcomes, patient-reported outcomes, pharma

Patient-reported outcomes measures are an invaluable tool in ensuring that the patient remains in the driving seat when it comes …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

July 26, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Biohaven, FDA, Lyrica, NICE, Pfizer, UK, US, pharma, top ten

At the end of a week that could certainly be called “eventful” here in the UK – one that saw …
london-2393098_960_720

London’s water contains high levels of antibiotic-resistant genes, UCL research reveals

July 26, 2019 Medical Communications, Research and Development London, UCL, UK, antibiotic resistance, pharma

Research from University College London has warned that freshwater sources in the English capital of London contain high levels of …
https__cdn

GW Pharma’s cannabis-based Epidyolex edges closer to EU approval with positive CHMP opinion in epilepsy

July 26, 2019 Medical Communications, Sales and Marketing EMA, Epidiolex, Europe, GW Pharma, cannabis, epilepsy

UK-based biotech GW Pharmaceuticals has announced that its cannabidiol oral solution Epidyolex has secured recommendation from the European Medicines Agency’s …

J&J’s ponesimod meets primary and secondary endpoints at Phase 3 in relapsing multiple sclerosis

July 26, 2019 Medical Communications, Research and Development Johnson & Johnson, multiple sclerosis, pharma, ponesimod

New Phase 3 data has been released on Johnson & Johnson’s selective sphingosine-1-phosphate receptor 1 (S1P1) modulator ponesimod, reporting that …

AstraZeneca’s Lynparza approved via Cancer Drugs Fund for BRCA+ gynaecological cancers

July 26, 2019 Medical Communications, Sales and Marketing AstraZeneca, Cancer, Cancer Drugs Fund, NHS, NICE, UK, lynparza, pharma

NICE has published final guidance which approves AstraZeneca’s Lynparza (olaparib) for use on the NHS as a maintenance therapy for …
reshma-bio-image

Vertex promote chief medical officer to CEO as Jeffrey Leiden steps down

July 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Reshma Kewalramani has been made the new Vertex CEO. Vertex’s Chief Medical Officer Dr Kewalramani will succeed current CEO …
christi_shaw

Christi Shaw taken on by Gilead as Kite Pharma’s new CEO

July 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lilly veteran Christi Shaw has joined Kite Pharma as the company’s new CEO. Shaw comes to Gilead’s cancer immunotherapy firm, …

Elizabeth Warren calls on Albert Bourla to reveal detail of appointment of former FDA commissioner Scott Gottlieb to Pfizer’s board

July 25, 2019 Business Services, Medical Communications Albert Bourla, Elizabeth Warren, FDA, Pfizer, Scott Gottlieb, pharma

Elizabeth Warren has called on Pfizer to reveal the details of Scott Gottlieb’s appointment to the company’s Board of Directors.
The Gateway to Local Adoption Series

Latest content